Bellevue Group »

Autolus Therapeutics Plc spon ads shares owned by Bellevue Group

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $322k 50k 6.44
2019-12-31 $821k 62k 13.20
2019-09-30 $430k 35k 12.43
2019-06-30 $547k 34k 16.09

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Intra Cellular Therapies (ITCI)
Moderna (MRNA)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Abbott Laboratories (ABT)
Revolution Medicines (RVMD)
Stryker Corporation (SYK)
Incyte Corporation (INCY)
Axonics Modulation Technolog (AXNX)
Dex (DXCM)

View all positions for Bellevue Group

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Paradigm Biocapital Advisors
Polygon Management
Cormorant Asset Management
Frazier Life Sciences Management
T. Rowe Price Associates
Perpetual
Lynx1 Capital Management
Perceptive Advisors
Bank of New York Mellon
Fred Alger Management
Laurion Capital Management
Walleye Trading Advisors
Alphabet

View all funds holding Autolus Therapeutics Plc spon ads